High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis
- 24 June 2005
- journal article
- clinical trial
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 9 (2) , 158-163
- https://doi.org/10.1007/s10157-005-0354-y
Abstract
Accumulating evidence suggests that oxidative stress is enhanced in patients on regular hemodialysis (HD). Iron supplementation is essential for the treatment of renal anemia, but there is a possibility that it could enhance oxidative stress by inducing the Fenton reaction. Here, we report our investigation of the relation between iron storage and DNA oxidative injury in HD patients.The study subjects were 48 patients on regular HD (age, 62.7 +/- 12.1 years; HD duration, 67.2 +/- 62.5 months; non-diabetic/diabetic; 22:26). Patients who were positive for hepatitis C virus antibody (HCV Ab), or hepatitis B surface antigen (HBsAg), and those with inflammatory or malignant diseases were excluded. The serum 8-hydroxy-2'-deoxyguanosine (8-OHdG) level, a marker of DNA oxidative injury, was measured before the first HD session of the week in all patients, and factors associated with high serum 8-OHdG were investigated. In 9 patients with a serum ferritin level of more than 1000 ng/ml at study entry, serum 8-OHdG levels were followed up for 6 months in the absence of iron supplementation.Multivariate analysis showed that the serum ferritin level was a significant and independent determinant of serum 8-OHdG, and serum ferritin correlated significantly with the total dose of iron supplementation during the 6-month period of the study. In the nine patients, without iron supplementation, serum 8-OHdG levels, as well as serum ferritin, decreased significantly during follow-up.Our results suggest that increased iron storage may induce DNA oxidative injury in patients on regular HD, and that the serum ferritin level is a surrogate marker for this pathological condition.Keywords
This publication has 26 references indexed in Scilit:
- Effects of HMG-CoA Reductase Inhibitors on Endothelial FunctionCirculation, 2004
- OXIDATIVE DNA DAMAGE IN PATIENTS WITH PROSTATE CANCER AND ITS RESPONSE TO TREATMENTJournal of Urology, 2004
- Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal DiseaseCirculation, 2002
- Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?Atherosclerosis, 1997
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron statusFree Radical Biology & Medicine, 1994
- Determination of Kt/V and Protein Catabolic Rate Using Pre- and Postdialysis Blood Urea Nitrogen ConcentrationsNephron, 1994
- Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repairCarcinogenesis: Integrative Cancer Research, 1986
- Serum FerritinCRC Critical Reviews in Clinical Laboratory Sciences, 1979